|
Code
|
Display
|
|
1601-4
|
Breast abscess or mastitis |
|
1602-2
|
Myocarditis or pericarditis |
|
1603-0
|
Clinical sepsis |
|
1604-8
|
Deep incisional primary surgical site infection (SSI) |
|
1605-5
|
Deep incisional secondary surgical site infection (SSI) |
|
1606-3
|
Vertebral disc space infection |
|
1607-1
|
Ear or mastoid infection (otitis externa, otitis media, otitis interna, mastoiditis) |
|
1608-9
|
Eye infection, other than conjunctivitis |
|
1609-7
|
Gastrointestinal tract infection (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis |
|
1610-5
|
Intraabdominal infection, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere |
|
1611-3
|
Intracranial infection (brain abscess, subdural or epidural infection, encephalitis) |
|
1612-1
|
Joint or bursa infection |
|
1613-9
|
Laboratory-confirmed bloodstream infection |
|
1614-7
|
Other infections of lower respiratory tract, other than pneumonia |
|
1615-4
|
Meningitis or ventriculitis |
|
1616-2
|
Oral cavity infection (mouth, tongue, or gums) |
|
1617-0
|
Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections) |
|
1618-8
|
Other infections of the urinary tract (kidney, ureter, bladder, urethra, or tissue surrounding the retroperitoneal or perinephric space) |
|
1619-6
|
Spinal abscess without meningitis |
|
1620-4
|
Superficial incisional primary surgical site infection (SSI) |
|
1621-2
|
Superficial incisional secondary surgical site infection (SSI) |
|
1622-0
|
Upper respiratory tract infection, pharyngitis, laryngitis, epiglottitis |
|
1623-8
|
Arterial or venous infection |
|
1624-6
|
Vaginal cuff infection |
|
1625-3
|
Symptomatic UTI (SUTI) |
|
1626-1
|
Pneumonia 1 (PNU1) |
|
1631-1
|
Pneumonia 2 (PNU2) |
|
1632-9
|
Pneumonia 3 (PNU3) |
|
1640-2
|
Organ/space |
|
1671-7
|
Bronchitis or tracheitis |
|
1672-5
|
Burn infection |
|
1673-3
|
Decubitus ulcer infection |
|
1674-1
|
Disseminated infection |
|
1675-8
|
Infant pustulosis |
|
1676-6
|
Newborn circumcision infection |
|
1677-4
|
Soft tissue, muscle, lymph node, or salivary gland infection |
|
1970-3
|
Periprosthetic joint infection |
|
2343-4
|
Ventilator-associated condition (VAC) |
|
2344-2
|
Infection-related ventilator-associated complication (IVAC) |
|
2345-0
|
Possible ventilator-associated pneumonia (PVAP) |
|
2402-6
|
Asymptomatic bacteremic UTI (ABUTI) |
|
3066-8
|
Neonatal Laboratory Confirmed Bloodstream Infection 1 (NLCBI 1) |
|
3067-6
|
Neonatal Laboratory Confirmed Bloodstream Infection 2 (NLCBI 2) |
|
3068-4
|
Neonatal Laboratory Confirmed Meningitis 1 (NLCM 1) |
|
3069-2
|
Neonatal Laboratory Confirmed Meningitis 2 (NLCM 2) |
|
1901-8
|
Not cultured |
|
1902-6
|
Blood culture not done or no organisms detected in blood |
|
1903-4
|
New onset/change in sputum |
|
1904-2
|
New onset/worsening cough, dyspnea, tachypnea |
|
1905-9
|
Other evidence of infection found |
|
1906-7
|
Other signs and symptoms |
|
1907-5
|
New onset or change in sputum, increased secretions or increased suctioning |
|
1908-3
|
Bradycardia or tachycardia |
|
1909-1
|
Occult or gross blood in stools (with no rectal fissure) |
|
1920-8
|
Localized swelling |
|
1921-6
|
Rales or bronchial breath sounds |
|
1922-4
|
Wheezing, rales or rhonchi |
|
1923-3
|
Greater than or equal to 5% bronchoalveolar lavage cells with bacteria |
|
1924-0
|
Imaging test evidence of infection |
|
1925-7
|
New or progressive and persistent infiltrate |
|
1926-5
|
Pneumatoceles (in <=1 year old) |
|
1927-3
|
One positive culture with >=100,000 cfu/ml with no more than 2 species of microorganisms |
|
1928-1
|
Positive dipstick for leukocyte esterase or nitrate |
|
1929-9
|
Greater than or equal to 2 positive urine cultures with >=100 cfu/ml of same uropathogen from non-voided specimen |
|
1930-7
|
One positive culture with <=100,000 cfu/ml of a single uropathogen in patient being treated with an effective antimicrobial agent for UTI |
|
1931-5
|
Greater than or equal to 2 positive urine cultures with >=100,000 cfu/ml with no more than 2 organisms |
|
1934-9
|
Positive detection of viral antigen or antibody |
|
1935-6
|
Fourfold rise in paired sera for pathogen |
|
1936-4
|
Positive culture or microimmunofluorescence of Legionella species |
|
1937-2
|
Legionella pneumophila serogroup 1 antigens in urine |
|
1938-0
|
Fourfold rise in Legionella pneumophila antibody titer |
|
1939-8
|
Matching positive blood and sputum cultures with Candida species |
|
1940-6
|
Fungi or Pneumocystis carinii from lower respiratory tract specimen |
|
1941-4
|
Other positive laboratory tests |
|
1942-2
|
More than 15 colonies cultured from intravascular cannula tip using semi-quantitative culture method |
|
1943-0
|
Positive Gram stain when culture is negative or not done |
|
1944-8
|
Common commensal from >=2 blood cultures |
|
1946-3
|
Organism(s) identified from pleural fluid |
|
1947-1
|
Positive quantitative culture from lower respiratory tract (LRT) specimen |
|
1948-9
|
Positive culture of virus or Chlamydia |
|
1949-7
|
Positive PCR for Chlamydia or Mycoplasma |
|
1950-5
|
Positive microimmunofluorescence test for Chlamydia |
|
1951-3
|
Recognized pathogen from one or more blood cultures |
|
1952-1
|
Positive culture |
|
1953-9
|
Positive culture of pathogen |
|
1954-7
|
Positive culture of skin contaminant |
|
1955-4
|
Positive blood culture |
|
1956-2
|
Histopathologic exam with abscess formation or lung parenchyma invasion by fungal hyphae |
|
1957-0
|
Acute onset of diarrhea (liquid stools for >12 hours) |
|
1958-8
|
Worsening gas exchange |
|
1959-6
|
Apnea, tachypnea, nasal flaring with retraction of chest wall or grunting |
|
1960-4
|
Pain or tenderness |
|
1962-0
|
Physician institutes appropriate antimicrobial therapy |
|
1963-8
|
Physician diagnosis of this event type |
|
1964-6
|
Allogeneic hematopoietic stem cell transplant (allo-SCT) with grade >=3 gastrointestinal graft-versus-host disease (GI GVHD) |
|
1965-3
|
Allogeneic hematopoietic stem cell transplant (allo-SCT) with diarrhea |
|
1966-1
|
Positive culture from >=2 separate tissue or fluid samples from affected joint |
|
1967-9
|
Incision deliberately opened or drained |
|
1968-7
|
Sinus tract |
|
1971-1
|
Acute pain, swelling, or tenderness of testes, epididymis, or prostate |
|
1972-9
|
Urine not tested for white blood cells |
|
2320-0
|
Wound (not related to vascular access) with pus or increased redness |
|
2346-5
|
Daily minimum FiO2 increase >=0.20 (20 points) for >=2 days |
|
2347-3
|
Daily minimum PEEP increase >=3 cm H2O for >=2 days |
|
2348-1
|
Temperature >38°C or <36°C |
|
2349-9
|
White blood cell count >=12,000 or <=4,000 cells/mm3 |
|
2350-2
|
A new antimicrobial agent(s) is started, and is continued for >=4 days |
|
2351-1
|
Criterion 1: positive culture from endotracheal aspirate without purulent respiratory secretions |
|
2352-5
|
Criterion 1: positive culture from bronchoalveolar lavage without purulent respiratory secretions |
|
2353-3
|
Criterion 1: positive culture from lung tissue without purulent respiratory secretions |
|
2354-1
|
Criterion 1: positive culture from protected specimen brush without purulent respiratory secretions |
|
2355-9
|
Criterion 2: purulent respiratory secretions plus organism(s) |
|
2356-4
|
Criterion 2: organisms from sputum culture with purulent respiratory secretions |
|
2357-2
|
Criterion 2: organisms from endotracheal aspirate culture with purulent respiratory secretions |
|
2358-0
|
Criterion 2: organisms from bronchoalveolar lavage culture with purulent respiratory secretions |
|
2359-8
|
Criterion 2: organisms from lung tissue culture with purulent respiratory secretions |
|
2360-1
|
Criterion 2: organisms from protected specimen brush culture with purulent respiratory secretions |
|
2361-0
|
Criterion 3: positive test for organism(s) identified from pleural fluid |
|
2362-4
|
Criterion 3: positive test for lung histopathology |
|
2363-2
|
Criterion 3: positive diagnostic test for Legionella species |
|
2364-0
|
Criterion 3: positive diagnostic test for selected viral pathogens |
|
2403-4
|
One positive culture with >=1,000 cfu/ml and <100,000 cfu/ml with no more than 2 species of microorganisms |
|
2513-0
|
Bilateral infiltrates on chest x-ray |
|
2514-8
|
Diffuse hemorrhage |
|
2515-5
|
Nausea/vomiting |
|
2516-3
|
Criterion not otherwise specified |
|
2517-1
|
Pain not otherwise specified |
|
2518-9
|
Rash not otherwise specified |
|
3070-0
|
Common commensal from blood specimen(s) and antibiotics for >=5 days |
|
3071-8
|
Recognized pathogen from cerebrospinal fluid specimen |
|
3072-6
|
Common commensal from cerebrospinal fluid specimen and antibiotics for >=5 days |